Brief: Lee's Pharmaceutical Holdings Says Qtrly Revenue Of HK$368.3 Mln
25/11/2021 10:13
Nov 25 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* QTRLY REVENUE HK$368.3 MILLION VERSUS HK$337.3 MILLION
* QTRLY PROFIT ATTRIBUTABLE HK$13.8 MILLION VERSUS HK$25
MILLION
Source text for Eikon: ID:nHKS3XVPZc
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA